Tweets
Download available--Difficult RA Defined
https://t.co/6WGMEiwiUk
Links:
Dr. John Cush @RheumNow ( View Tweet )
18 hours 23 minutes ago
RheumNow podcast now available! Listen on SoundCloud and Apple/Android podcasts.
https://t.co/P6kaqZP0PJ https://t.co/BPQ5Ey7d0r
Links:
Dr. John Cush @RheumNow ( View Tweet )
20 hours 53 minutes ago
"... think what others won’t think;
go where others won’t go;
do what others won’t do;
and be what others want to be."
- Phil knight
Dr. John Cush @RheumNow ( View Tweet )
21 hours 7 minutes ago
News Feature: Baricitinib Therapy in Covid-19 Pneumonia
https://t.co/b3tsLcoXay https://t.co/tjqkk1RLFZ
Links:
Dr. John Cush @RheumNow ( View Tweet )
23 hours 53 minutes ago
Download available--Arthritis Myths
https://t.co/2Kxpou4Fbz
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 day 13 hours ago
We have a robust agenda planned for RheumNow Live. Have you registered yet?
https://t.co/3zMtzt4t2H https://t.co/iLNj8XEu4X
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 day 17 hours ago
QD Clinic - Remission Time
What to do when not quite in remission
https://t.co/BjALXBPVYm https://t.co/HftUANlU1b
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 day 20 hours ago
RheumNow LIVE VOTE Survey (RHEUMS only):
What Kind of Rheumatologist are You?
General Rheum?
Selective Rheum?
Specialized Rheum?
please vote in our quick 4Q survey https://t.co/2c5fIgcJ5X https://t.co/LgK8yiXEWC
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 day 21 hours ago
Influenza Numbers are way down this year due to COVID mitigation methods, school/office closings, reduced travel/mobility. As of Jan 31st only 155 hospitalized with the flu (98% less than 2019-2020 flu season - 8,633 people were hospitalized with the flu) https://t.co/6c2YQKbt57?
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 day 21 hours ago
News Feature: Weight Loss to Avert Risk of Gout
https://t.co/wzf69PvSJc https://t.co/Dph4OAC2Ar
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 day 22 hours ago
2021 Rheumatollgy drugs lead television advertising spending: #1 Humira ($65.8 million); #6 Xeljanz ($33.9 mill); #7 Skyrizi ($40 mill); #8 Enbrel ($25.8mill); #9 Rinvo ($12+ mill) https://t.co/Pan9Vr5kLt
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 days 1 hour ago
Today the FDA approved tocilizumab (Actemra) for use in Systemic Sclerosis-Associated Interstitial Lung Disease for "Slowing the rate of decline in pulmonary function in adult patients with SSc-ILD" Rec dose is 162 mg SC q week (IV dose not approved) https://t.co/HXTRPiYEfZ
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 days 12 hours ago